Search Results - Cmunt, E

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    P676: LOW‐DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP

    P676: LOW‐DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CL... by Smolej, L., Brychtová, Y., Cmunt, E., Oršulová, M., Vodárek, P., Dostál, M., Turcsányi, P., Urbanová, R., Panovská, A., Zuchnická, J., Mihályová, J., Lysák, D., Brejcha, M., Móciková, H., Klásková, K., Šimkovič, M., Špaček, M., Doubek, M.

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

    Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition) by Jonasova, A, Neuwirtova, R, Polackova, H, Siskova, M, Tomas, S, Cmunt, E, Belickova, M, Fuchs, O, Moudra, A, Michalova, K, Zemanova, Z

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    P-202 MDS development risk in CLL patients with prolonged cytopenia after fludarabine, cyclophosphamide and rituximab (FCR) régime

    P-202 MDS development risk in CLL patients with prolonged cytopenia after fludarabine, cyclophosphamide and rituximab (FCR) régime by Jonasova, A, Obrtlikova, P, Siskova, M, Cmunt, E, Berkova, A, Karban, J, Svackova, K, Trneny, M

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    191 - Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

    191 - Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition) by Jonasova, A., Neuwirtova, R., Polackova, H., Siskova, M., Tomas, S., Cmunt, E., Belickova, M., Fuchs, O., Moudra, A., Michalova, K., Zemanova, Z.

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    97 Expression of CD36 (GPIIIb) on platelets in MDS

    97 Expression of CD36 (GPIIIb) on platelets in MDS by Neuwirtová, R., Holada, K., Valterová, L., Cmunt, E., Kvasnicˇka, J., Malasková, V., Kessler, P., Dyr, J.E.

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia

    Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia by Šindelářová, Lenka, Michalová, Kyra, Zemanová, Zuzana, Ransdorfová, Šárka, Březinová, Jana, Peková, Soňa, Schwarz, Jiří, Karban, Josef, Cmunt, Eduard

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide

    Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry... by Schwarz, Jiří, Ovesná, Petra, Černá, Olga, Kissová, Jarmila, Soukupová, Jacqueline Maaloufová, Brychtová, Yvona, Doubek, Michael, Červinek, Libor, Cmunt, Eduard, Dulíček, Petr, Campr, Vít, Křen, Leoš, Penka, Miroslav

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: